Study of Pazopanib in the Treatment of Surgically Unresectable or Metastatic Liposarcoma

Clinical trial NCT01506596 · COMPLETED

Trial details

NCT number: NCT01506596
Sponsor: Vector Oncology
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Liposarcoma Surgically Unresectable Liposarcoma Metastatic Liposarcoma

Start date: 2012-03-01
Primary completion: 2014-10-01
Enrollment: 42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.